Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2019
Sep. 30, 2018
Current assets:    
Cash and cash equivalents $ 6,295,152 $ 3,759,509
Accounts receivable, net 5,021,057 3,972,632
Inventory, net 3,647,406 2,302,030
Prepaid expenses and other current assets 1,843,297 1,148,345
Total current assets 16,806,912 11,182,516
Plant and equipment, net 351,895 404,552
Deferred income taxes 8,433,669 8,543,758
Intangible assets, net 20,168,495 20,477,729
Goodwill 6,878,932 6,878,932
Other assets 988,867 965,152
Total assets 53,628,770 48,452,639
Current liabilities:    
Accounts payable 3,124,751 3,226,036
Accrued research and development costs 2,475,490 981,357
Accrued compensation 1,597,197 687,248
Accrued expenses and other current liabilities 1,436,888 1,778,409
Credit agreement, short-term portion (Note 9) 5,385,649 6,692,718
Unearned revenue   187,159
Total current liabilities 14,019,975 13,552,927
Credit agreement, long-term portion (Note 9) 2,886,382 2,701,570
Residual royalty agreement (Note 9) 3,845,518 1,753,805
Deferred income taxes 296,605 844,758
Other liabilities 247,154 118,161
Total liabilities 21,295,634 18,971,221
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock; no shares issued and outstanding at September 30, 2019 and 2018, respectively
Common stock, par value $0.01 per share; 154,000,000 and 77,000,000 shares authorized, 67,221,951 and 57,468,660 shares issued and 65,038,247 and 55,284,956 shares outstanding at September 30, 2019 and 2018, respectively 672,220 574,687
Additional paid-in-capital 110,268,057 95,496,506
Accumulated other comprehensive loss (581,519) (581,519)
Accumulated deficit (70,219,017) (58,201,651)
Treasury stock, 2,183,704 shares, at cost (7,806,605) (7,806,605)
Total stockholders' equity 32,333,136 29,481,418
Total liabilities and stockholders' equity $ 53,628,770 $ 48,452,639